After the approval of Premier Li Keqiang, the State Council issued the "Made in China 2025" and deployed a comprehensive strategy to promote the implementation of the manufacturing power. This is the action plan for China’s implementation of the first decade of the strategy of manufacturing a strong country. Focusing on the strategic goal of manufacturing a strong country, "Made in China 2025" has defined nine strategic tasks and priorities: first, to improve the national manufacturing innovation capability; second, to promote the in-depth integration of informatization and industrialization; third, to strengthen industrial infrastructure; fourth Strengthening the construction of quality brands; Fifth, comprehensively promoting green manufacturing; sixth, vigorously promoting breakthrough development in key areas, focusing on the new generation of information technology industry, high-end CNC machine tools and robots, aerospace equipment, offshore engineering equipment and high-tech ships, advanced rail transit equipment Ten key areas such as energy conservation and new energy vehicles, power equipment, agricultural machinery and equipment, new materials, biomedicine and high-performance medical equipment; seventh, deepening the adjustment of manufacturing structure; eighth, actively developing service-oriented manufacturing and production services Nine is to improve the level of international development of manufacturing. "Made in China 2025" proposes to develop biomedical and high-performance medical devices. Development of new products for chemical drugs, traditional Chinese medicines and biotechnology drugs for major diseases, including new mechanisms and new target chemical drugs, antibody drugs, antibody-conjugated drugs, new structural proteins and peptide drugs, new vaccines, and outstanding clinical advantages Chinese medicine and personalized treatment drugs. We will improve the innovation capability and industrialization level of medical devices, and focus on the development of high-performance medical equipment such as imaging equipment and medical robots, high-value Medical Consumables such as fully degradable vascular stents, and mobile medical products such as wearable and remote medical treatment. Breakthrough and application of new technologies such as biological 3D printing and induced pluripotent stem cells. APIs And Parmaceutical Intermediates Apis And Parmaceutical Intermediates,Pitavastatin Calcium,Tropisetron Hydrochloride,Lipoic Acid Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com